tiprankstipranks
Advertisement
Advertisement

ALVO Stock Latest News

Alvotech Earnings Call: Growth Momentum Meets FDA Risk
Company AnnouncementsAlvotech Earnings Call: Growth Momentum Meets FDA Risk
2d ago
ALVO
Alvotech price target lowered to $4 from $8 at Deutsche Bank
PremiumThe Fly
Alvotech price target lowered to $4 from $8 at Deutsche Bank
11d ago
ALVO
Alvotech price target lowered to $4 from $5 at Barclays
PremiumThe Fly
Alvotech price target lowered to $4 from $5 at Barclays
11d ago
ALVO
Alvotech: Regulatory Setbacks Priced In, Biosimilar Strength Supports Buy Rating Despite Lowered Target
PremiumRatings
Alvotech: Regulatory Setbacks Priced In, Biosimilar Strength Supports Buy Rating Despite Lowered Target
11d ago
ALVO
Alvotech price target lowered to $6 from $10 at UBS
PremiumThe Fly
Alvotech price target lowered to $6 from $10 at UBS
11d ago
ALVO
Alvotech price target lowered to $4 from $5 at Barclays
PremiumThe FlyAlvotech price target lowered to $4 from $5 at Barclays
12d ago
ALVO
Alvotech Posts Strong 2025 Growth, Adds Approvals and New CEO as Biosimilar Pipeline Expands
Premium
Company Announcements
Alvotech Posts Strong 2025 Growth, Adds Approvals and New CEO as Biosimilar Pipeline Expands
16d ago
6K
ALVO
Is ALVO a Buy, Before Earnings?
Premium
Pre-Earnings
Is ALVO a Buy, Before Earnings?
19d ago
ALVO
Alvotech Discloses Intra-Group Transfer of 2.7 Million Shares Within Aztiq Group
PremiumCompany Announcements
Alvotech Discloses Intra-Group Transfer of 2.7 Million Shares Within Aztiq Group
1M ago
6K
ALVO
Alvotech Hits Pivotal Milestone With Positive PK Data for Entyvio Biosimilar AVT80
PremiumCompany Announcements
Alvotech Hits Pivotal Milestone With Positive PK Data for Entyvio Biosimilar AVT80
2M ago
6K
ALVO
Alvotech Strikes Sandoz Biosimilar Supply and Commercialization Deals in Canada, Australia and New Zealand
PremiumCompany Announcements
Alvotech Strikes Sandoz Biosimilar Supply and Commercialization Deals in Canada, Australia and New Zealand
2M ago
6K
ALVO
Alvotech Finalizes Global Patent Settlement for Eylea Biosimilar, Clears Path for 2026 Launches
PremiumCompany Announcements
Alvotech Finalizes Global Patent Settlement for Eylea Biosimilar, Clears Path for 2026 Launches
2M ago
6K
ALVO
Alvotech Corrects Disclosure on December 2025 Insider-Related Share Transactions
PremiumCompany AnnouncementsAlvotech Corrects Disclosure on December 2025 Insider-Related Share Transactions
3M ago
6K
ALVO
Alvotech Reports Major Insider-Related Share Purchases Filed in Luxembourg
Premium
Company Announcements
Alvotech Reports Major Insider-Related Share Purchases Filed in Luxembourg
3M ago
6K
ALVO
Alvotech Founder Róbert Wessman to Hand CEO Role to Lisa Graver in Planned Q1 2026 Succession
Premium
Company Announcements
Alvotech Founder Róbert Wessman to Hand CEO Role to Lisa Graver in Planned Q1 2026 Succession
3M ago
6K
ALVO
Alvotech CEO Robert Wessman to step down, Lisa Graver to succeed
PremiumThe Fly
Alvotech CEO Robert Wessman to step down, Lisa Graver to succeed
3M ago
ALVO
Alvotech Raises USD 100 Million Term Loan to Bolster Biosimilar Growth and 2026 Launches
PremiumCompany Announcements
Alvotech Raises USD 100 Million Term Loan to Bolster Biosimilar Growth and 2026 Launches
3M ago
6K
ALVO
Alvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz
PremiumCompany Announcements
Alvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz
3M ago
6K
ALVO
Alvotech and Teva Settle With Regeneron on U.S. Launch Timing for Eylea Biosimilar AVT06
PremiumCompany Announcements
Alvotech and Teva Settle With Regeneron on U.S. Launch Timing for Eylea Biosimilar AVT06
4M ago
6K
ALVO
Alvotech, Teva reach settlement and license agreement with Regeneron for AVT06
PremiumThe FlyAlvotech, Teva reach settlement and license agreement with Regeneron for AVT06
4M ago
ALVO
REGN
Alvotech Completes $108 Million Convertible Bond Offering to Drive R&D and Biosimilar Launches
Premium
Company Announcements
Alvotech Completes $108 Million Convertible Bond Offering to Drive R&D and Biosimilar Launches
4M ago
6K
ALVO
Alvotech initiated with an Underweight at Barclays
Premium
The Fly
Alvotech initiated with an Underweight at Barclays
4M ago
ALVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >